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The analysis of intraepithelial lymphocytes (IEL) by flow cytometry of duodenal biopsies – the 3 
‘IEL’ lymphogram - has been proposed as a diagnostic test for coeliac disease.  However, its 4 
clinical applicability has been limited due to variability in methods and definitions.  This study 5 
set out to define useful parameters for the application of the IEL lymphogram to the diagnosis 6 
of coeliac disease. 7 
Design 8 
Flow cytometry was performed on 117 sets of duodenal biopsies in 107 adult patients with 9 
active coeliac disease, long-term coeliac disease on a gluten free diet and a control group.  The 10 
initial 95 samples were used for hypothesis generation for the subsequent samples comprising 11 
12 patients with coeliac disease and 10 controls. 12 
Results 13 
Rather than using single linear cut-offs for CD3 and TCR + IELs, a discriminant function was 14 
identified as %CD3+ve IELs + 2x(%TCR + IELs) > 100.  This differentiated coeliac disease from 15 
control biopsies in the hypothesis generating group.  These results were replicated in the 16 
validation group and found to be independent of histology in patients on long term gluten free 17 
diet up to 12 years (combined sensitivity, 98.5%; specificity 97.7%).    18 
Conclusions 19 
Flow cytometric analysis of intraepithelial lymphocytes is a highly sensitive and specific 20 
adjunct to serology and histological examination for the diagnosis of coeliac disease, even in 21 
individuals with coeliac disease following a gluten free diet who exhibit normal duodenal 22 
histology.   23 
  24 
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What is already known about this subject? 
Duodenal intra epithelial lymphocyte (IEL) populations are altered in coeliac 
disease compared to normal.  This is the basis of the ‘IEL’ lymphogram using 
flow cytometry of fresh intestinal biopsies.  It has been applied to the diagnosis 
of coeliac disease using specified cut offs for CD3-ve and gamma delta T cell 
receptor (  TCR) +ve cells. 
What are the new findings?   
This study demonstrates that CD3+ve and  TCR+ve IELs are dependently 
variable such that a simple linear function combining both can discriminate 
coeliac from non-coeliac individuals with ~98% sensitivity and specificity.  This is 
independent of gluten ingestion or histological appearances.   
How might it impact on clinical practice in the foreseeable future? 
The use of flow cytometry can strengthen the diagnosis of coeliac disease where 
it is not clear cut.  Flow cytometry could be used on a follow up biopsy on diet to 
both assess response and confirm the diagnosis on a single endoscopic 
procedure where the diagnosis has been made by serology alone, as occurred 
during the COVID-19 pandemic.   
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Introduction 31 
The diagnosis of coeliac disease requires the identification of serum immunoglobulin-A (IgA) 32 
antibodies targeting tissue-transglutaminase 2 (TTG) or deamidated gliadin peptides (DGP), 33 
confirmed by the finding of characteristic changes on histological examination of biopsies 34 
taken from the duodenum.  Both tools require ongoing gluten ingestion1-3.   35 
However, neither provides a ‘gold standard’ for the diagnosis of coeliac disease.  Antibody 36 
levels may be sufficient to make the diagnosis when present in high titre in both children and 37 
adults4,5, but low levels may be associated with marginal or absent histological changes in 38 
duodenal biopsies6.   Coeliac disease-associated antibodies may be absent altogether from the 39 
serum but detectable within the lamina propria complexed with TTG7.   40 
Similarly, the interpretation of biopsies may be hampered by sampling error, cross-cutting of 41 
sections and minimal changes, and there is wide inter-observer variability between reporting 42 
pathologists.   The characteristic histological features associated with coeliac disease are also 43 
found in other conditions8,9.  The presence or absence of symptoms is an unreliable indicator 44 
of coeliac disease10, and assessment of human leucocyte antigen haplotye (HLA) is only helpful 45 
to rule out the condition when non-compatible11.   46 
The increase in numbers of intestinal intraepithelial lymphocytes (IELs) is well reported in the 47 
active coeliac lesion and often persists long-term on a gluten free diet8.  Recently, it has 48 
become clear that in addition, the phenotypic composition of the IELs remains permanently 49 
altered12,13.  Studies of duodenal IELs reveal reduced CD3-ve cells and an increase in T cells 50 
and it has been suggested that this could be used as a tool for the diagnosis of coeliac disease14-51 
16  A recent study using the proportion of CD3+ve cells expressing the T cell receptor to 52 
differentiate coeliac individuals from normal controls resulted in a 66.3% sensitivity with a 53 
96.6% specificity at a cut off of 14%17.   54 
In this study we set out to determine whether this ‘IEL lymphogram’ could be further refined 55 
for diagnostic application in coeliac disease.   56 
 57 
Patients and Methods 58 
Patients considered likely to require mucosal biopsy were recruited into the study and gave 59 
their consent for additional biopsies to be taken from the second part of the duodenum to be 60 
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used for flow cytometric analysis.  Patients were categorized into three groups: control (CON) 61 
- subjects with normal duodenal histological appearances referred for gastroscopy for diverse 62 
reasons; Active coeliac disease (ACD) – subjects with positive serum anti-tissue 63 
transglutaminase antibodies and characteristic duodenal biopsy features of coeliac disease at 64 
time of diagnosis or ongoing villous atrophy with or without elevated anti-TTG antibody 65 
titres;   Long-term coeliac disease (LTCD) – subjects diagnosed previously with coeliac disease 66 
on long term gluten free diet and with normal mucosal appearances on duodenal histological 67 
examination.  68 
At the time of upper gastrointestinal endoscopic examination biopsies (n=5) were taken into 69 
formalin for histological examination and additional biopsies (n=10) into normal saline for 70 
flow cytometry.  IELs were isolated using an adaption of a standard technique18,19 as follows: 71 
the epithelium was separated and disaggregated by vigorous mechanical disaggregation using 72 
a vortex mixer (VWR) in the presence of dithiothreitol (1 mM) and ethylene diamine tetra-73 
acetic acid, EDTA (1 mM).  The cellular extract was centrifuged and washed in phosphate 74 
buffered saline supplemented with 0.45% human albumin. Washed cells were incubated at 75 
room temperature in the dark with fluorochrome-conjugated antibodies to the cell surface 76 
antigens. Following a further 2 wash cycles, cell permeabilisation was then performed 77 
according to manufacturers’ instructions (Fix and Perm kit Nordic-MUbio) before incubation 78 
with the intracellular CD3 conjugated antibody.  The antibody panel was established for 79 
diagnostic purposes in refractory coeliac disease and included detection of intracellular 80 
(cytoplasmic) CD3 expression separately from cell surface CD3 expression.   The full panel 81 
comprised the following antibody markers:  CD2, CD3, CD4, CD5, CD7, CD8, CD30, CD38, 82 
CD45, CD56, CD103, CD335, T-cell receptor  and  T cell receptor   Data was acquired using 83 
a BD FACSCantoII three laser configuration flow cytometer, and analysed using BD FACS diva 84 
software (v 6.1.3).  The lymphocytes were gated by CD45 and low side scatter characteristics. 85 
Cytoplasmic and surface staining of CD3 was included in the common backbone across all 86 
panels and used for selectively identify the different IEL populations - surface/cytoplasmic 87 
CD3+, surface CD3-/cytoplasmic CD3+ and CD3-. 88 
Results from the first 95 samples were analysed to generate a hypothesis for appropriate cut 89 
off values for subsequent lymphogram categorization.  The subsequent 22 samples were used 90 
as a ‘validation’ group to assess the validity of the discriminant parameters for the test. 91 
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A student t-test was used at significance of p<0.01 between datasets.  Ethical permission for 92 
this study was granted by the research ethics service (14/WA/1270, January 2015) and the local 93 
research and development department.   94 
 95 
Results 96 
Patient details are tabulated in table 1.    The commonest indications for gastroscopy in the 97 
control group (CON) were iron deficiency anaemia and functional bowel symptoms (39% in 98 
each).  Other indications (one or two patients each) included unexplained weight loss, 99 
unexplained diarrhoea, abnormal cross-sectional radiology, and two patients had undergone 100 
small intestinal transplantation with biopsies taken of the proximal graft.    101 
The active group (ACD) of 44 subjects included eight patients with seropositive type 1 102 
refractory coeliac disease at diagnosis, yet despite becoming seronegative over a period of 103 
years; on follow up still had ongoing villous atrophy.  These eight patients underwent routine 104 
follow up with flow cytometric analysis on an annual basis with the results remaining 105 
consistent on separate occasions demonstrating intra-individual reproducibility. 106 
Of those in the LTCD group, an IgA Anti-TTG antibody titre was available for only 12 107 
individuals at initial diagnosis, although a further nine were reported from elsewhere as 108 
‘positive’ and two were not done.  Six patients underwent initial diagnostic biopsy elsewhere 109 
and were reported as showing confirmatory changes, 14 were carried out at diagnosis in 110 
Cambridge and all showed villous atrophy of which 10 were sub-total.   IgA anti-TTG antibody 111 
titre at follow up biopsy was available for 13 patients as it is not standard practice in 112 
Cambridge to use this assay during follow up.  The median duration of adherence to a gluten 113 
free diet was 5.5 years, with a range of 1 – 50 years.  Two patients with the longest duration of 114 
gluten free diet maintained since diagnosis had been diagnosed at a time when confirmatory 115 
duodenal biopsies and antibody tests were not available (44 and 50 years respectively).  Of the 116 
remainder in this group, nine had followed a strict gluten free diet for three years or more, and 117 
three had done so for 10 years or more (up to 12 years).   118 
The proportions of cells by flow cytometry expressing surface CD3 and T-cell receptor  (TCR 119 
) are shown in figure 1 (a,b) by category.  The proportions of CD3+ cells are the proportion of 120 
all gated lymphocytes – whereas the proportion of TCR + cells is the proportion of CD3+ cells 121 
expressing the TCR  receptor.   122 
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There is significant overlap between the CON, ACD and LTCD groups with regard to both 123 
CD3 and TCR  proportions.  The sensitivity of using a diagnostic cut off for TCR  of 14% in 124 
the ACD group was 64% and in the LTCD group, 57%.  The specificity based on the one 125 
patient with a high TCR  proportion in the CON group is 97%.   126 
However, when surface and cytoplasmic CD3 positive cell proportions are charted against TCR 127 
 positive T cell proportions, there is a clear separation of ACD and CON groups as shown in 128 
figure 2 (a,b).  The discriminant function between the non-coeliac and the coeliac groups is a 129 
simple linear equation which corresponds to [%CD3 + 2x(%TCR ) >100] (fig 1c). 130 
The validation cohort comprised 12 samples from patients with active coeliac disease and 10 131 
without.  None of these samples were from the individuals in the ACD cohort that had 132 
previously undergone flow cytometric analysis.   Of those with coeliac disease in the validation 133 
group, 58% were male with a median age age of  56 years (compared with 56% and 60 years in 134 
the hypothesis generating group).  Of those without coeliac disease, 40% were male with 135 
median age 34 years (compared with 40% and 59.5 years in the hypothesis generating group). 136 
The average discriminant function was respectively 131 (range 104-151) for the active coeliac 137 
patients and 65.5 (range 54-96) for non-coeliac patients, thereby correctly identifying all 138 
subsequent patients in each group.  The validation and hypothesis-generating groups have 139 
been combined in subsequent data analysis.  140 
It can be noted that (due to the long-term persistence of altered IEL phenotypes in coeliac 141 
disease) the IEL lymphogram is indistinguishable between the LTCD (fig 2c) and the ACD (fig 142 
2a) groups, of which 63/67 (94%) show a discriminant function of >100.  However, on closer 143 
inspection of the four outlying cases, one was borderline (99.2) and two were those that had 144 
been diagnosed before any diagnostic tests were available, 44 and 50 years previously.  Both of 145 
these were challenged by prolonged (>three months) gluten ingestion and re-biopsied.  Both 146 
remained symptom free, seronegative and with normal repeat duodenal biopsies and chose to 147 
eat gluten thereafter.  One further patient had been diagnosed 10 years previously in a 148 
children’s hospital on the basis of anti-gliadin antibody positivity alone, but did not undergo 149 
histological confirmation and was negative for both anti-TTG and endomysial antibodies.  150 
This patient chose to continue a gluten free diet.  Therefore, on the assumption that two of 151 
these three patients did not have coeliac disease, and the evidence for the third patient having 152 
the condition was extremely weak, the sensitivity of flow cytometry in the remaining 64 cases 153 
increases to 98.44% (95% confidence intervals 91.60% - 99.96%).   154 
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In terms of specificity, 1/40 non-coeliac/control patients had a discriminant function >100.  155 
This patient had no reported symptoms or family history and was seronegative for anti-TTG 156 
antibodies.  The HLA DQ status was not known.  This gives a specificity of 97% for flow 157 
cytometry in this setting (97.67% including the three deemed unlikely to have coeliac disease 158 
as above, with 95% confidence intervals of 87.7% - 99.94%).   159 
Discussion 160 
The utility of the IEL lymphogram in the diagnosis of coeliac disease has been described in a 161 
recent meta-analysis20.  Of the six studies included, only five reported an ‘IEL lymphogram’ 162 
based on proportions of CD3-ve and TCR +ve IELs12,14-16,21.  Two of these studies were 163 
specifically in children12,16 and the other three were mixed paediatric and adult populations.  164 
Methods varied between studies including gating strategies:  three additionally gated cell 165 
populations for CD103 positivity, and one for CD7 positive cells.  There is great diversity of IEL 166 
phenotype, especially within the CD3-ve population which also comprises a subset expressing 167 
cytoplasmic CD3 but lacking surface CD3 and this may add to the variability between studies 168 
relying on CD3-ve populations.   169 
In addition, of those five studies using measurement of CD3-ve IELs by flow cytometry (by 170 
various definitions), only one provided the relevant cut-offs applied for their ‘lymphogram’14.  171 
In this case a lymphogram comprising > 8.5% TCR  and <10% CD3-ve IELs gave a sensitivity 172 
and specificity of 85% and 100% respectively.  This demonstrates a better sensitivity than the 173 
use of TCR proportions alone20.  Applying these ‘IEL lymphogram’ criteria to our data would 174 
provide a sensitivity of 64% and a specificity of 92.5%. Despite lacking information on the cut-175 
offs applied, a further study reported the sensitivity and specificity of the IEL lymphogram in 176 
adults as 89% and 96% respectively15.   177 
In our study, in order to simplify the IEL lymphogram and to remove possible confounding 178 
variables, we selected lymphocytes by their CD45 high/low side scatter properties, measuring 179 
proportions of CD45+CD3+ and CD45+CD3+TCR  IELs.  The plot of %CD3+ve IELs against 180 
%TCR +ve IELs was able to differentiate the samples from controls and those with active 181 
coeliac disease very effectively according to whether they lay above or below a line 182 
corresponding to the discriminant function: %CD3+ve + 2x(%TCR ) >100.  This gave a high 183 
sensitivity of 100% and a specificity of 97%.  The discriminant function in this instance was 184 
derived through charting and identification of separate populations.  With larger datasets it 185 
may be possible to define regions of interest mathematically with greater accuracy. 186 
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Application of our discriminant function to the LTCD group with normal histology on gluten 187 
free diet showed that four patients would have an IEL lymphogram considered incompatible 188 
with coeliac disease.  However, one of these was borderline, and on examination of diagnostic 189 
records and subsequent gluten challenge and biopsy, the other three were highly unlikely to 190 
have the condition.  The overall specificity and sensitivity of this test after combining the ACD 191 
and LTCD groups were 98.3% and 97.5% respectively.  The results from the LTCD group 192 
would suggest that this is an effective way of making – or refuting – the diagnosis of coeliac 193 
disease in individuals following a gluten free diet over many years without any changes on 194 
microscopic examination of duodenal biopsies, and without the need for undergoing a gluten 195 
challenge.  196 
The use of a separate validation cohort following the generation of a hypothesis ensured that 197 
the discriminant function used for diagnosis was reproducible within the single centre.  198 
However, the main weakness of this study is that it is from only one centre and laboratory and 199 
the findings will require corroboration.   Of note, transferability of results from studies of the 200 
IEL lymphogram between sites has not been possible to date given the different methods and 201 
definitions of IEL lymphogram applied.  It is hoped that this simplified test will provide the 202 
basis for comparison with results from other centres.  However, it is notable that using the 203 
same cut off just for TCR + cells in this study as those from another recent study17 gave 204 
equivalent values of sensitivity and specificity suggesting a degree of transferability of results 205 
between sites. 206 
Intra-individual reproducibility was also demonstrated in this study by the eight patients who 207 
underwent repeated flow cytometry analyses - the discriminant function differed by less than 208 
10% between tests (data not shown) and did not result in a change of diagnosis in any case. 209 
In this study we have demonstrated that the greatest utility of the IEL lymphogram is when a 210 
discriminant function is used that provides for adjustable, mutually dependent cut offs to be 211 
applied rather than simple independent linear cut-off levels for each variable as used in other 212 
IEL lymphograms.  It is unclear why many patients with coeliac disease do not exhibit an 213 
increase in TCR +ve IELs and why this should be compensated by TCR  cells, such that the 214 
combination of proportions of CD3+ve and TCR +ve cells becomes diagnostic rather than 215 
either alone.  In our data we were unable to find any difference in IEL subsets (using a variety 216 
of different cell surface markers) between those patients with coeliac disease in whom 217 
TCR proportions were low and those in which they were high.  It has previously been 218 
postulated that the age of the patient may dictate the TCR  response, however we were unable 219 
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to demonstrate any such association, in either the ACD or LTCD groups.  There were notable 220 
differences in gender distribution between the study groups.  It is unlikely that this skewed 221 
the data in this study as IEL subtypes are not thought to differ between sexes. 222 
Our method involved taking 10 additional biopsies.  This resulted in a prolongation of the 223 
procedure by under three minutes as the biopsies were taken as ‘double bites’ – there being no 224 
requirement for architectural interpretation.  This is a much larger amount of tissue than is 225 
strictly necessary as we applied our standard immunostaining protocols used for analysis of 226 
biopsies for refractory coeliac disease and to look for additional potential biomarkers.  However, in 227 
the longer term, the number of additional biopsies could be reduced to just one or two for 228 
flow cytometry if limited to analysis of surface CD3 and TCR  markers for diagnostic 229 
purposes, as used in other centres (15).   230 
The potential clinical utility of the IEL lymphogram has been demonstrated in this study but 231 
in view of the relatively small sample sizes will require larger scale studies to validate.  Many 232 
cases of coeliac disease are ‘challenging’ to diagnose on the basis of weak seropositivity and 233 
low-grade changes in the biopsies.  The addition of flow cytometry as an additional tool can 234 
strengthen the diagnosis.  It is notoriously difficult for patients to undergo gluten challenge 235 
for re-biopsy and results may not be definitive due to poor compliance with the challenge 236 
protocol.  The use of flow cytometry also obviates this requirement.  This may be of particular 237 
relevance in the COVID-19 period when gluten free diets were started on the basis of 238 
seropositivity alone.  Indeed, for those centres where routine practice includes a confirmatory 239 
diagnostic biopsy and a subsequent follow up biopsy for assessment of response, the use of 240 
flow cytometry could abolish the requirement for a diagnostic biopsy and be carried out on 241 
the follow up biopsy alone.  The laboratory cost of flow cytometry in our institution is 242 
equivalent to that of a gastroscopy and therefore this would be a cost-effective pathway to 243 
both confirm the diagnosis and to assess the response to diet in one procedure.  244 
  245 
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Figure 1:   Box and whisker plots of values of %CD3+ IELs as a proportion of all CD45+ 247 
lymphocytes (a), % TCR  + IELs as a proportion of all CD3+ IELs (b) and ‘discriminant 248 
function’ values (%CD3+ IELs + 2x(%TCR  + IELs)) (c) for control (CON), active coeliac 249 
disease (ACD), long-term coeliac disease (LTCD) and LTCD and ACD groups combined. 250 
Figure 2:   Scatter plots of %CD3+ IELs as a proportion of all CD45+ lymphocytes (X-axis) 251 
charted against % TCR  + IELs as a proportion of CD3+ IELs (Y-axis), showing the 252 
discriminant function (%CD3+ IELs + 2x(%TCR  + IELs)) as a line.  a) Active coeliac disease 253 
(ACD), b) control (CON), c) Long-term coeliac disease on diet (LTCD). 254 
 255 
  256 
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